Immune Checkpoint Inhibitor Induced Pericarditis and Encephalitis in a Patient Treated With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report and Review of the Literature

被引:6
|
作者
Braden, Jorja [1 ]
Lee, Jenny H. [1 ,2 ]
机构
[1] Chris OBrien Lifehouse, Dept Med Oncol, Sydney, NSW, Australia
[2] Macquarie Univ, Dept Biomed Sci, Sydney, NSW, Australia
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
immunotherapy; melanoma; immune-related adverse effects; pericarditis; encephalitis; delayed immune reaction; ADVERSE EVENTS;
D O I
10.3389/fonc.2021.749834
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune checkpoint inhibitors (ICIs) have dramatically improved outcomes in melanoma. Common ICI toxicities have become familiar to clinicians; however, rare delayed toxicities remain challenging given the paucity of data with such presentations. We present the unique case of a 61-year-old with metastatic melanoma with two rare, delayed ICI-induced toxicities. After resection of a large symptomatic parietal metastases, this patient received two doses of combination ipilimumab and nivolumab. Five weeks following his second dose, he developed ICI-induced pericarditis with associated pericardial effusion and early signs of tamponade. Corticosteroids were not administered due to a concurrent cerebral abscess. Administration of colchicine, ibuprofen, judicious monitoring, and cessation of immunotherapy led to the complete resolution of the effusion over several weeks. Seven months following his last dose of immunotherapy, the patient developed ICI-associated grade four autoimmune encephalitis, presenting as status epilepticus. High-dose steroid initiation led to rapid clinical improvement. The patient remains in near-complete response on imaging with no recurrence of pericardial effusion and partial resolution of neurological symptoms. ICI-induced pericardial disease and encephalitis carry substantial mortality rates and prompt diagnosis and management is critical. Clinicians must therefore remain vigilant for these rare toxicities regardless of duration of drug exposure or time since cessation of therapy.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Ipilimumab/Nivolumab for Immune Checkpoint Inhibitor-induced Encephalitis
    Janssen, Sarah
    Lindhof, Harm-Henning
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 166 - 166
  • [2] A Rare Case of Autoimmune Encephalitis in a Patient After Treatment of Metastatic Melanoma with a Combination of Immune Checkpoint Inhibitors Nivolumab and Ipilimumab
    Tadipatri, Ramya
    Tarzi, F. Philip
    [J]. NEUROLOGY, 2020, 94 (15)
  • [3] Encephalitis in a Patient With Melanoma Treated With Immune Checkpoint Inhibitors: Case Presentation and Review of the Literature
    Gkoufa, Aikaterini
    Gogas, Helen
    Diamantopoulos, Panagiotis T.
    Ziogas, Dimitrios C.
    Psichogiou, Mina
    [J]. JOURNAL OF IMMUNOTHERAPY, 2020, 43 (07) : 224 - 229
  • [4] Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
    Feifei Wang
    Yang Liu
    Wei Xu
    Changjing Zhang
    Jianhong Lv
    Shaolin Ma
    [J]. Journal of Medical Case Reports, 15
  • [5] Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
    Wang, Feifei
    Liu, Yang
    Xu, Wei
    Zhang, Changjing
    Lv, Jianhong
    Ma, Shaolin
    [J]. JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [6] Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature
    Abdallah, Al-Ola
    Herlopian, Aline
    Ravilla, Rahul
    Bansal, Meghana
    Chandra-Reddy, Sowmya
    Mahmoud, Fade
    Ong, Shirley
    Gokden, Murat
    Hutchins, Laura
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (03) : 537 - 542
  • [7] Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review
    Di Stefano, Rosario F.
    Buttigliero, Consuelo
    De Luca, Emmanuele
    Reale, Maria Lucia
    Pisano, Chiara
    Leone, Gianmarco
    Zichi, Clizia
    Massa, Federica
    Manfredi, Matteo
    Vignani, Francesca
    Bollito, Enrico
    Porpiglia, Francesco
    Di Maio, Massimo
    Tucci, Marcello
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : E1087 - E1090
  • [8] Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review
    Marin A. McDonald
    Parag Sanghvi
    Julie Bykowski
    Gregory A. Daniels
    [J]. BMC Cancer, 18
  • [9] Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review
    McDonald, Marin A.
    Sanghvi, Parag
    Bykowski, Julie
    Daniels, Gregory A.
    [J]. BMC CANCER, 2018, 18
  • [10] Double Whammy: A Case Report of Immune Checkpoint Inhibitor Colitis and Concomitant CMV Colitis in a Patient on Nivolumab for Metastatic Melanoma
    Jahagirdar, Vinay
    Mahadevia, Himil
    Palmen, Ronald
    Sanders, Kimberly
    Campbell, John
    Sylvestre, Pamela B.
    Chhabra, Rajiv
    Clarkston, Wendell
    Jonnalagadda, Sreeni S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1624 - S1625